Kangmei Pharma | 600518 - Operating Profit

Stock Price
1.79
Daily Change
0.02 1.13%
Monthly
-4.28%
Yearly
-8.67%
Q2 Forecast
1.71

Kangmei Pharma reported CNY-26.7M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.41M 742K Dec/2025
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Genomma Lab Internacional MXN 800.61M 167.16M Dec/2025
Hypermarcas BRL 647.2M 26.39M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Jiangsu Hengrui CNY 2.25B 848.02M Dec/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Sh Fosun Pharma CNY 864.14M 105.76M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -157.5M 392M Dec/2025
Wuxi Apptec CNY 4.67B 293.95M Dec/2025
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025
Zz Pientze Pharmaceu CNY 501.33M 52.54M Sep/2025